Michigan Biomedical Venture Fund (MBVF) invests in and supports University of Michigan life science startup companies, including therapeutics, medical devices, diagnostics, and health IT.
Follow for posts about Michigan’s life science | medtech 🩻| biotech 🧬| digital health 🏥startup ecosystem. Join our virtual community of investors and advisors who can help advance impactful startups.
Founded based on an initial gift from the Monroe-Brown Foundation, MBVF makes seed-stage investments and provides support to help companies reach key milestones and attract additional investors. This evergreen fund serves to strengthen the critical pipeline between research and the biomedical innovation life cycle, create broad clinical and economic impact through startups, and continue to attract world-class talent to U-M’s entrepreneurial ecosystem.
This fund is exclusively for biomedical startups with U-M IP / license. Most applicants need to complete a translational program (including Coulter, MTRAC, NSF I-Corps). MBVF is a collaborative effort between the U-M College of Engineering’s Center for Entrepreneurship (CFE) and U-M Medical School’s Fast Forward Medical Innovation (FFMI).
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2016
Founded
Investors
0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Michigan Biomedical Venture Fund founded?
Michigan Biomedical Venture Fund was founded in 2016.
What industry is Michigan Biomedical Venture Fund in?
Michigan Biomedical Venture Fund operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Michigan Biomedical Venture Fund based?
Michigan Biomedical Venture Fund is headquartered in ANN ARBOR, United States.
Find investors for your startup like Michigan Biomedical Venture Fund
Gritt sends AI-personalised outreach to each investor — from your Gmail